上海才致药成

Shanghai Caizhi Yaocheng Pharmaceutical Technology is an innovative biotechnology company based in Shanghai, China, specializing in AI-driven small molecule drug discovery. The company leverages its proprietary 'CaiZhi' platform, which integrates advanced bioinformatics, computational chemistry, and machine learning to identify novel therapeutic targets and optimize lead compounds. Its research focus is primarily directed toward high-value biological pathways in oncology and immunology, aiming to develop first-in-class or best-in-class therapies. Founded by a team of prominent experts in bioinformatics and medicinal chemistry, the company seeks to significantly accelerate the drug R&D process and improve clinical success rates. Caizhi Yaocheng has secured early-stage funding from leading venture capital firms to advance its internal pipeline and enhance its computational capabilities. The company is currently operating in the pre-clinical and IND-enabling stages for its lead research programs.